Bird Flu (H5N1 Avian Influenza) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed
Conditions: Influenza, Human; Influenza in Birds; Respiratory Tract Infections; Infections; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Diseases Interventions: Biological: aH5N6c on Day 1; Biological: aH5N6c on Day 22; Biological: Placebo on Day 22 Sponsor: Seqirus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine
Condition: Influenza, Human Intervention: Biological: H5N1 antigen combined with MF59 adjuvant Sponsor: Seqirus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials